Alioth

Series-B
aliothbio.com Biotech & Healthcare Shanghai, China
Total Funding $14.3M
Latest Round $14.3M Series-B
Last Announced Jan 15, 2026
Investors 10 Backers
Decision Makers Profile Active

About Alioth

艾里奥斯生物科技(上海)有限公司,专注于制药过程过滤产品及技术的开发和应用,并致力于为制药企业提供符合国内外法规要求的高质量的分离、纯化解决方案。 艾里奥斯聚焦“膜材料”技术的创新与突破,在美国波士顿和中国上海组建了由国际知名膜技术科学家领衔的研发团队,持续研发具有自主知识产权的高性能过滤膜材和过滤器产品,为制药企业的过滤工艺优化保驾护航。 同时,艾里奥斯遵循ISO9001质量体系并参考GMP要求,在上海等地自建了超过15,000m2的过滤膜和过滤器生产基地,拥有通过CNAS认证的验证中心、工艺开发实验室等配套设施,以更好地保障制药企业的供应链安全和药品生产安全,助力制药企业的创新发展。

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Shanghai, China
Tracked Since Nov 17, 2026

Web & Domain Identity

Official Website aliothbio.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $14,350,000 · Series-B

    aliothbio.com

Investors & Backers

10
AstraZeneca CICC Medical Industry Fund
EFung Capital
Guohai Innovative CCI Capital
Guoshun Investment
Hony Capital
Longpan Investment
Matrix Partners China
QF Capital
SDIC Unity Capital
Xuhui State Investment Group

Funding History

1 Round
Series-B equity · Jan 15, 2026
$14,350,000 aliothbio.com

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts